Insider · CIK 0001394522

Tobias Jeffrey K

Reports to the SEC for 2 companies · SAN MATEO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001394522

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, R&D & CMO	FTax Payment	−1,630 sh	$174.76	−$285K	38,484
2015-02-27	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, R&D & CMO	FTax Payment	−704 sh	$170.09	−$120K	40,114
2015-02-26	JAZZJazz Pharmaceuticals plcA Award	EVP, R&D & CMO	AAward	+5,755 sh	—	—	40,818
2015-02-26	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)A Award	EVP, R&D & CMO	AAward	+570 sh	—	—	570
2015-02-26	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)A Award	EVP, R&D & CMO	AAward	+14.4K sh	—	—	14,430
2015-02-10	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	+5,000 sh	$46.83	+$234K	40,063
2015-02-10	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−3,000 sh	$166.48	−$499K	37,063
2015-02-10	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−2,000 sh	$167.34	−$335K	35,063
2015-02-10	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	−5,000 sh	—	—	25,019
2014-11-24	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−4,598 sh	$170.12	−$782K	34,940
2014-11-14	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−1,000 sh	$173.32	−$173K	39,538
2014-10-10	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−1,000 sh	$154.04	−$154K	40,538
2014-09-12	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−1,000 sh	$171.22	−$171K	41,538
2014-08-11	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, R&D & CMO	FTax Payment	−4,565 sh	$133.86	−$611K	42,538
2014-08-11	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	+2,561 sh	$46.83	+$120K	45,099
2014-08-11	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	+2,372 sh	$59.13	+$140K	47,471
2014-08-11	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−4,933 sh	$135.42	−$668K	42,538
2014-08-11	JAZZJazz Pharmaceuticals plc · Nonstatutory Stock Option (right to buy)M Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	−2,561 sh	—	—	30,019
2014-08-11	JAZZJazz Pharmaceuticals plc · Nonstatutory Stock Option (right to buy)M Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	−2,372 sh	—	—	17,187
2014-03-10	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	+1,281 sh	$46.83	+$60K	49,384
2014-03-10	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	+1,719 sh	$59.13	+$102K	51,103
2014-03-10	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−3,000 sh	$152.99	−$459K	48,103
2014-03-10	JAZZJazz Pharmaceuticals plc · Nonstatutory Stock Option (right to buy)M Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	−1,281 sh	—	—	36,421
2014-03-10	JAZZJazz Pharmaceuticals plc · Nonstatutory Stock Option (right to buy)M Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	−1,719 sh	—	—	21,718
2014-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, R&D & CMO	FTax Payment	−1,174 sh	$157.60	−$185K	48,103
2014-02-27	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−3,000 sh	$165.46	−$496K	41,777
2014-02-27	JAZZJazz Pharmaceuticals plcA Award	EVP, R&D & CMO	AAward	+7,500 sh	—	—	49,277
2014-02-27	JAZZJazz Pharmaceuticals plc · Nonstatutory Stock Option (right to buy)A Award	EVP, R&D & CMO	AAward	+14.4K sh	—	—	14,355
2014-02-27	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)A Award	EVP, R&D & CMO	AAward	+645 sh	—	—	645
2014-02-10	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	+2,560 sh	$46.83	+$120K	47,337
2014-02-10	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−2,560 sh	$152.83	−$391K	44,777
2014-02-10	JAZZJazz Pharmaceuticals plc · Nonstatutory Stock Option (right to buy)M Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	−2,560 sh	—	—	37,702
2013-12-09	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	+1,325 sh	$46.83	+$62K	46,102
2013-12-09	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−1,325 sh	$117.80	−$156K	44,777
2013-12-09	JAZZJazz Pharmaceuticals plc · Nonstatutory Stock Option (right to buy)M Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	−1,325 sh	—	—	40,262
2013-11-11	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	+2,373 sh	$46.83	+$111K	46,778
2013-11-11	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−2,373 sh	$98.50	−$234K	44,405
2013-11-11	JAZZJazz Pharmaceuticals plc · Nonstatutory Stock Option (right to buy)M Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	−2,373 sh	—	—	41,587
2013-10-14	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	+5,000 sh	$46.83	+$234K	49,405
2013-10-14	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−4,400 sh	$82.53	−$363K	45,005
2013-10-14	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−600 sh	$83.31	−$50K	44,405
2013-10-14	JAZZJazz Pharmaceuticals plc · Nonstatutory Stock Option (right to buy)M Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	−5,000 sh	—	—	43,960
2013-09-09	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	+5,000 sh	$46.83	+$234K	49,405
2013-09-09	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−5,000 sh	$87.11	−$436K	44,405
2013-09-09	JAZZJazz Pharmaceuticals plc · Nonstatutory Stock Option (right to buy)M Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	−5,000 sh	—	—	48,960
2013-08-12	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	+7,500 sh	$46.83	+$351K	51,905
2013-08-12	JAZZJazz Pharmaceuticals plcS Sale	EVP, R&D & CMO	SSale	−7,500 sh	$80.77	−$606K	44,405
2013-08-12	JAZZJazz Pharmaceuticals plc · Nonstatutory Stock Option (right to buy)M Exercise/Conversion	EVP, R&D & CMO	MExercise/Conversion	−7,500 sh	—	—	54,140
2013-08-09	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, R&D & CMO	FTax Payment	−3,288 sh	$80.88	−$266K	44,405
2013-03-05	JAZZJazz Pharmaceuticals plcA Award	EVP, R&D & CMO	AAward	+12.5K sh	—	—	47,500

Recent filings

Accepted (ET)
Mar 94
Jazz Pharmaceuticals plc0001232524-15-000062
SEC(opens sec.gov)
Mar 24
Jazz Pharmaceuticals plc0001232524-15-000044
SEC(opens sec.gov)
Feb 124
Jazz Pharmaceuticals plc0001232524-15-000017
SEC(opens sec.gov)
Nov 254
Jazz Pharmaceuticals plc0001232524-14-000146
SEC(opens sec.gov)
Nov 184
Jazz Pharmaceuticals plc0001232524-14-000145
SEC(opens sec.gov)
Oct 144
Jazz Pharmaceuticals plc0001232524-14-000125
SEC(opens sec.gov)
Sep 154
Jazz Pharmaceuticals plc0001232524-14-000123
SEC(opens sec.gov)
Aug 134
Jazz Pharmaceuticals plc0001232524-14-000111
SEC(opens sec.gov)
Mar 124
Jazz Pharmaceuticals plc0001232524-14-000029
SEC(opens sec.gov)

Companies

Address

C/O NEUROGESX, INC. 2215 BRIDGEPOINTE PARKWAY, SUITE 200

SAN MATEO, CA, 94404